Business
WuXi Biologics Extends Global CRDMO Network to Qatar Through Strategic MoU Signed with Qatar Free Zones Authority
WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has signed a strategic Memorandum of Understanding (MoU) with the Qatar Free Zones Authority (QFZ) to extend WuXi Biologics' global network and capabilities to the Middle East.
About this update from Wuxi Biologics (cayman) Inc.
[{"type":"text","content":"DOHA, Qatar, Dec. 2, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has signed a strategic Memorandum of Understanding (MoU) with the Qatar Free Zones Authority (QFZ) to extend WuXi Biologics' global network and capabilities to the Middle East.","length":360,"tagName":"p"},{"type":"image","alt":"The MoU signing was witnessed by H.E. Sheikh Faisal bin Thani bin Faisal Al-Thani, Minister of Commerce and Industry – State of Qatar and Chairman of Qatar Free Zones Authority (QFZ), and was signed by H.E. Sheikh Mohammed Bin Hamad Bin Faisal Al-Thani, CEO of Qatar Free Zones Authority, and Dr. Chris Chen, CEO of WuXi Biologics.","displaySize":"","headline":null,"caption":"The MoU signing was witnessed by H.E. Sheikh Faisal bin Thani bin Faisal Al-Thani, Minister of Commerce and Industry – State of Qatar and Chairman of Qatar Free Zones Authority (QFZ), and was signed by H.E. Sheikh Mohammed Bin Hamad Bin Faisal Al-Thani, CEO of Qatar Free Zones Authority, and Dr. Chris Chen, CEO of WuXi Biologics.","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":279,"url":"https://media.zenfs.com/en/prnewswire.com/439719177b94cae5bd0b17f102f6d47b"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/JtSnWv9rM_h1NS8LKAHNEA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ5MjtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/439719177b94cae5bd0b17f102f6d47b","width":400,"height":279}},"href":"https://mma.prnewswire.com/media/2836125/WuXi_Biologics.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"The strategic collaboration paves the way for the establishment of WuXi Biologics' first integrated CRDMO center in the Middle East. By combining WuXi Biologics' globally recognized one-stop CRDMO solutions, innovative technologies, and expertise in complex biologics (such as bispecifics & multispecifics, antibody-drug conjugates) with Qatar's strategic vision for biopharmaceutical advancement, this collaboration aims to drive innovation, accelerate the growth of Qatar's biotechnology sector, while jointly propel the development of a robust Middle Eastern biopharmaceutical ecosystem.","length":615,"tagName":"p"},{"type":"text","content":"Dr. Chris Chen, CEO of WuXi Biol...